Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05512364
Title Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA) (TREAT ctDNA)
Acronym TREAT ctDNA
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors European Organisation for Research and Treatment of Cancer - EORTC
Age Groups: adult | senior
Covered Countries ITA | FRA | DEU | BEL

No variant requirements are available.